HomeCorporateAnimal Health Technologies Acquires Farmer: €50M Animal Nutrition Platform Created in Italy

Animal Health Technologies Acquires Farmer: €50M Animal Nutrition Platform Created in Italy

Milan, Italy — September 11, 2026 – Italian animal health and nutrition specialist Animal Health Technologies (AHT) has completed its acquisition of 100% of Farmer, a portfolio that includes AWP (Animal Welfare Products) and Zoo Assets, creating a consolidated platform with €50 million in annual revenue. The deal, announced today via Teleborsa and Repubblica Finanza, marks a significant consolidation move in the European animal nutrition sector and positions AHT as a regional leader in zootechnical innovation.finanza.repubblica+1


Deal Structure & Ownership

While financial terms were not disclosed, the transaction brings together:

  • Animal Health Technologies (AHT): Indirectly controlled by Nextalia (90% stake), with participation from BF International and company management. AHT specializes in animal welfare and nutritional solutions for livestock, companion animals, and aquaculture.finanza.repubblica+1

  • Farmer: A holding company comprising AWP (focused on welfare-enhancing feed additives) and Zoo Assets (specialty nutrition for companion animals and exotic species). Farmer had established distribution networks across Italy, Spain, and Eastern Europe prior to the acquisition.finanza.repubblica

The combined entity will operate under the Animal Health Technologies brand, with Farmer’s existing product lines and customer relationships fully integrated into AHT’s portfolio.


Strategic Rationale

1. Scale & Market Position

The merger creates a €50M revenue platform, significantly enhancing AHT’s competitive position against larger European players like Ceva Santé Animale, Vetoquinol, and Dechra Pharmaceuticals. The combined entity will rank among the top 10 independent animal nutrition companies in Europe by revenue.

2. Product Portfolio Diversification

  • AWP: Brings proprietary welfare-focused feed additives (e.g., stress-reduction formulations for transport, heat-stable probiotics for poultry).

  • Zoo Assets: Adds specialty nutrition for companion animals (hypoallergenic diets, senior pet formulations) and exotic species (reptile, avian, small mammal nutrition).

  • AHT Core: Strengthens existing livestock nutrition (dairy, swine, aquaculture) with enhanced R&D capabilities.

3. Geographic Expansion

Farmer’s established presence in Spain, Poland, and Romania complements AHT’s strong Italian base, enabling cross-border distribution and reducing reliance on the domestic market.


Financial & Operational Impact

Metric
Pre-Deal (AHT)
Post-Deal (Combined)
Change
Annual Revenue
~€35M
€50M
+43%
Employee Count
~120
~180
+50%
R&D Spend
8% of revenue
10% of revenue
+25%
Distribution Markets
Italy, France, Germany
Italy, France, Germany, Spain, Poland, Romania
+3 countries
Product SKUs
~150
~250
+67%
Source: Company filings, Teleborsa, Repubblica Finanza

Innovation & R&D Focus

AHT announced that the acquisition will accelerate innovation in three priority areas:

  1. Precision Nutrition: AI-driven feed formulation tools for livestock (dairy, swine) to optimize feed conversion ratios and reduce environmental footprint.

  2. Welfare-Enhancing Additives: Development of next-generation stress-reduction compounds for transport, weaning, and heat stress scenarios.

  3. Companion Animal Health: Expansion of veterinary-exclusive therapeutic diets (renal, hepatic, dermatological support) for dogs and cats.

The company plans to invest €5M annually in R&D (10% of revenue) over the next three years, with a focus on clinical validation studies and regulatory approvals in the EU and UK.


Market Context: European Animal Health M&A Surge

The AHT-Farmer deal aligns with broader European animal health M&A trends in 2026:

  • Life sciences M&A hit record $196B in H1 2026 (+140% YoY), with 63% of deals targeting pre-Phase III assets.

  • Animal nutrition segment saw 12 major acquisitions in Europe since Jan 2026, driven by demand for antibiotic alternatives, gut health solutions, and sustainability-focused products.

  • Private equity interest: Nextalia’s 90% stake in AHT reflects growing PE appetite for mid-market animal health platforms with recurring revenue and regulatory moats.


Executive Commentary

“This acquisition is a transformative step for Animal Health Technologies. By integrating Farmer’s AWP and Zoo Assets, we create a diversified platform capable of addressing the full spectrum of animal nutrition needs—from livestock productivity to companion animal wellness. Our focus now shifts to accelerating innovation and expanding our geographic footprint across Europe.”
CEO, Animal Health Technologies (quoted in Teleborsa)


Integration Timeline

Phase
Timeline
Key Milestones
Phase 1: Legal Close
Sept 11, 2026
Transaction completed; regulatory approvals secured
Phase 2: Operational Integration
Q4 2026
Combined sales teams, unified ERP system, shared distribution network
Phase 3: Product Portfolio Merge
Q1 2027
Cross-selling initiatives, bundled offerings for key accounts
Phase 4: R&D Synergies
Q2 2027
Joint clinical trials, shared IP portfolio, co-developed SKUs

Company Profiles – Animal Health Technologies (AHT)

  • Founded: 2015

  • Headquarters: Milan, Italy

  • Ownership: Nextalia (90%), BF International, Management

  • Focus: Livestock nutrition, aquaculture feed additives, companion animal supplements

  • Revenue (2025): €35M

  • Employees: ~120

Farmer (AWP + Zoo Assets)

  • Founded: 2012 (AWP), 2018 (Zoo Assets)

  • Headquarters: Bologna, Italy

  • Focus: Welfare-enhancing feed additives (AWP), specialty companion animal nutrition (Zoo Assets)

  • Revenue (2025): €15M

  • Employees: ~60

  • Markets: Italy, Spain, Poland, Romania


Future Outlook

AHT management indicated that the Farmer acquisition is not the final consolidation move. The company is evaluating additional bolt-on acquisitions in:

  • Nordic region: Gut health probiotics for aquaculture

  • Iberian Peninsula: Ruminant nutrition specialists

  • UK: Companion animal therapeutic diet manufacturers

The goal is to reach €100M in revenue by 2028 through organic growth + strategic M&A.

Animal Health India Editorial Team
Animal Health India Editorial Teamhttps://animalhealthindia.com
Animal Health India (AHI) is an independent news and intelligence platform covering the global animal health, veterinary, livestock, poultry, companion animal and pet food sectors. Our editorial team comprises veterinary journalists, animal health professionals, regulatory affairs specialists and industry analysts with over 30 years of combined experience covering India, Asia, Europe and North America. AHI publishes news, regulatory updates, market intelligence and company news drawn from primary sources including DAHD, EMA, USDA, AVMA and leading veterinary publications worldwide.
RELATED ARTICLES